MacroGenics, Inc. (MGNX) DCF Valuation

Macrogenics, Inc. (MGNX) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
MacroGenics, Inc. (MGNX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

MacroGenics, Inc. (MGNX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus opciones de inversión con la calculadora DCF de Macrogenics, Inc. (MGNX)! Revise los datos financieros auténticos, ajuste las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estos cambios afectan el valor intrínseco de Macrogenics, Inc. (MGNX).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 62.0 97.8 75.6 151.9 58.7 69.6 82.4 97.5 115.5 136.8
Revenue Growth, % 0 57.62 -22.63 100.87 -61.33 18.42 18.42 18.42 18.42 18.42
EBITDA -177.2 -117.8 -190.9 -107.9 2.0 -51.1 -60.6 -71.7 -84.9 -100.6
EBITDA, % -285.67 -120.48 -252.31 -71.01 3.43 -73.52 -73.52 -73.52 -73.52 -73.52
Depreciation 12.3 12.0 11.3 11.9 9.6 9.9 11.7 13.9 16.4 19.5
Depreciation, % 19.83 12.23 14.88 7.81 16.42 14.23 14.23 14.23 14.23 14.23
EBIT -189.5 -129.7 -202.1 -119.8 -7.6 -54.5 -64.6 -76.4 -90.5 -107.2
EBIT, % -305.5 -132.71 -267.2 -78.82 -12.98 -78.36 -78.36 -78.36 -78.36 -78.36
Total Cash 215.8 272.5 243.6 154.3 229.8 69.6 82.4 97.5 115.5 136.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 12.7 23.1 10.4 56.2 10.4
Account Receivables, % 20.55 23.61 13.73 37 17.65
Inventories .0 .0 4.4 1.5 1.2 1.2 1.5 1.7 2.0 2.4
Inventories, % 0.000001612279 0.000001022871 5.8 0.95498 2.08 1.77 1.77 1.77 1.77 1.77
Accounts Payable 4.3 8.0 15.5 4.9 6.4 6.9 8.2 9.7 11.5 13.6
Accounts Payable, % 6.95 8.21 20.49 3.22 10.97 9.97 9.97 9.97 9.97 9.97
Capital Expenditure -4.3 -5.9 -6.2 -3.6 -1.8 -3.7 -4.4 -5.2 -6.1 -7.3
Capital Expenditure, % -6.92 -6.04 -8.2 -2.38 -3 -5.31 -5.31 -5.31 -5.31 -5.31
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -189.5 -117.8 -190.9 -120.0 -7.6 -52.9 -62.6 -74.2 -87.8 -104.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -189.9 -118.3 -170.0 -165.3 47.9 -51.5 -57.1 -67.6 -80.1 -94.9
WACC, % 12.83 12.77 12.79 12.83 12.83 12.81 12.81 12.81 12.81 12.81
PV UFCF
SUM PV UFCF -239.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -97
Terminal Value -895
Present Terminal Value -490
Enterprise Value -729
Net Debt -67
Equity Value -662
Diluted Shares Outstanding, MM 62
Equity Value Per Share -10.69

What You Will Gain

  • Comprehensive Financial Model: MacroGenics, Inc.'s (MGNX) actual data facilitates accurate DCF valuation.
  • Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates provide immediate feedback as you make adjustments.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Adaptable and Reusable: Designed for versatility, enabling ongoing use for in-depth forecasts.

Key Features

  • Customizable Financial Inputs: Adjust essential metrics such as revenue projections, R&D expenses, and operating costs.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics.
  • High-Precision Accuracy: Leverages MacroGenics’ actual financial data for dependable valuation results.
  • Streamlined Scenario Testing: Easily evaluate various assumptions and analyze the resulting impacts.
  • Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file for MacroGenics, Inc. (MGNX).
  2. Step 2: Review MacroGenics’ pre-filled financial data and projections.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you modify your assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for your investment strategies.

Why Choose This Calculator for MacroGenics, Inc. (MGNX)?

  • Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses in a single solution.
  • Customizable Inputs: Modify the yellow-highlighted cells to explore different scenarios.
  • Detailed Insights: Automatically computes MacroGenics' intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable starting points.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants.

Who Should Use This Product?

  • Investors: Accurately evaluate MacroGenics, Inc.’s (MGNX) fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to MacroGenics, Inc. (MGNX).
  • Consultants: Efficiently customize the template for valuation reports tailored to MacroGenics, Inc. (MGNX) clients.
  • Entrepreneurs: Acquire insights into the financial modeling practices of leading biotech firms like MacroGenics, Inc. (MGNX).
  • Educators: Employ it as a teaching resource to illustrate valuation methodologies relevant to MacroGenics, Inc. (MGNX).

What the Template Contains

  • Pre-Filled DCF Model: MacroGenics, Inc.’s (MGNX) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate MacroGenics, Inc.’s (MGNX) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.